Interstitial Granulomatous Drug Reaction to Ustekinumab
Interstitial granulomatous drug reaction (IGDR) is a distinct inflammatory process that often presents as annular, violaceous plaques distributed on the extremities, proximal trunk, and intertriginous areas. The list of drugs implicated for inciting IGDR is growing, but most prominently includes ACE...
Saved in:
Main Authors: | A. Walker, J. S. Westerdahl, J. Zussman, J. Mathis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Dermatological Medicine |
Online Access: | http://dx.doi.org/10.1155/2022/1461145 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Granulomatous Lymphocytic Interstitial Lung Disease in Infancy
by: Adetayo Adeleye, et al.
Published: (2014-01-01) -
Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
by: Bayanne Olabi, et al.
Published: (2020-01-01) -
Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial
by: Selma Atalay, et al.
Published: (2022-07-01) -
Efficacy and safety of ustekinumab in the treatment of moderate to severe plaque psoriasis in Singapore
by: Wai Sze Agnes Chan, et al.
Published: (2023-07-01) -
Granulomatous Osteonecrosis in Crohn’s Disease
by: Hugh J Freeman, et al.
Published: (2000-01-01)